Overview

Nonpharmacologic management strategies represent an important contribution to heart failure (HF) therapy. They may significantly impact patient stability, functional capacity, mortality, and quality of life. Most of the recommendations that follow derive from consensus expert opinion or are based on theory extrapolated from limited trial data in the elderly or chronic disease populations.